oxidopamine and sl 327
oxidopamine has been researched along with sl 327 in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Blake, BL; Breese, GR; Knapp, DJ; Papadeas, ST | 1 |
Blake, BL; Breese, GR; Halloran, C; McCown, TJ; Papadeas, ST | 1 |
Cenci, MA; Lindgren, HS; Ohlin, KE | 1 |
Other Studies
3 other study(ies) available for oxidopamine and sl 327
Article | Year |
---|---|
Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Animals, Newborn; Benzazepines; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Dopamine Agonists; Dopamine Antagonists; Enzyme Inhibitors; Female; Ketanserin; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nerve Tissue Proteins; Nucleus Accumbens; Oxidopamine; Phosphorylation; Prefrontal Cortex; Protease Inhibitors; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Serotonin 5-HT2 Receptor Antagonists | 2004 |
Changes in apical dendritic structure correlate with sustained ERK1/2 phosphorylation in medial prefrontal cortex of a rat model of dopamine D1 receptor agonist sensitization.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Dendrites; Dopamine Agonists; Flavonoids; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Oxidopamine; Phosphorylation; Prefrontal Cortex; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Sympatholytics | 2008 |
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 2009 |